ElderTech companies face unique GTM challenges — multi-stakeholder buyers, category education, accessibility requirements, and institutional sales cycles. A fractional CXO brings the senior leadership to navigate these complexities without the cost of a full-time hire.

The Problem

Your founding team built the product but can't build the market

Most eldertech founders have clinical, engineering, or caregiving backgrounds. They built a product that solves a real problem for aging populations. But building a product and building a market are different disciplines. The marketing, sales, and partnership strategies needed to scale an eldertech company require someone who has done it before — and your founding team is learning on the job.

You're selling to three audiences simultaneously with no playbook for any of them

ElderTech companies sell to older adults, family caregivers, and institutional buyers — each with different motivations, decision processes, and price sensitivity. Your one-person marketing team can't build three separate go-to-market motions. Without senior leadership to prioritize which audience drives growth and how to sequence the others, you're spreading resources too thin to break through with any of them.

Institutional sales cycles require a level of sophistication you haven't built yet

Health systems, PACE programs, senior living operators, and insurance companies have complex procurement processes. They need clinical evidence, security audits, compliance documentation, and references before they'll buy. If you're approaching these buyers with a startup pitch deck and a founder demo, you're not meeting their expectations. You need someone who understands enterprise healthcare procurement.

Investors want a growth story and you're still writing the first chapter

Your board expects a clear path from current revenue to the next funding milestone. They want to see defined ICPs, scalable channels, predictable pipeline, and improving unit economics. Without a growth executive to build and present this narrative — backed by real data and a real plan — fundraising conversations stall on questions about your commercial maturity.

How We Help

A fractional CXO from Winston Francois serves as your part-time growth executive — attending leadership meetings, directing your marketing team, interfacing with your board, and owning the commercial strategy. For eldertech companies, this role is particularly critical because the GTM challenges are multi-dimensional.

The first phase is diagnostic. We assess your product-market fit across each audience segment, evaluate your current marketing and sales infrastructure, and identify the highest-leverage growth opportunities. In eldertech, this often means making a hard choice about which buyer segment to prioritize first — a decision that most founding teams avoid because every segment feels equally important.

Once priorities are set, we build the growth engine. This includes developing positioning and messaging for priority segments, designing the channel strategy, building sales enablement materials for institutional buyers, and establishing the metrics infrastructure to track what's working. We direct your existing team, manage agency relationships, and fill capability gaps with specialist support from the Winston Francois team.

We also handle the organizational development work. As your company grows, the marketing and growth function needs to evolve. We help you identify when to make key hires, what profiles to look for, how to structure the team, and how to transition from a fractional model to full-time leadership. Many of our engagements include recruiting and onboarding the permanent CMO.

The operator mentality we bring means every strategic decision is connected to commercial outcomes. We don't do brand strategy for brand strategy's sake — we do it because clear positioning shortens sales cycles. We don't produce content for content's sake — we produce content that drives pipeline. Everything is measured by its impact on growth.

What we deliver

Growth diagnostic and 90-day prioritized plan — what to focus on first across your multi-segment market
Marketing strategy and execution leadership — directing your team, agencies, and specialist support
Institutional sales enablement — building the materials and processes for enterprise healthcare sales
Board reporting and investor narrative — translating growth activity into metrics that build confidence
Organizational design and hiring plan — building the marketing team you'll need at your next stage

ElderTech companies that try to sell to consumers, caregivers, and institutions simultaneously before they've won decisively in one segment almost always stall. The fractional CXO's most important job is often making the uncomfortable decision about which audience to deprioritize — and getting the rest of the leadership team aligned on that choice.

Our Methodology

Our fractional CXO engagements follow a 90-day sprint structure. The first 30 days are intensive discovery — we audit your marketing, interview customers and prospects, review competitive positioning, assess your sales pipeline, and evaluate team capabilities. We deliver a growth strategy document with a prioritized action plan and clear success metrics.

Days 30-60 are execution and infrastructure building. We implement the highest-priority initiatives, establish operating rhythms (weekly standups, biweekly leadership syncs, monthly board reports), and begin building the measurement infrastructure to track what's working. For eldertech, this often includes building the institutional sales toolkit alongside consumer or caregiver acquisition programs.

Days 60-90 are optimization. With campaigns running and processes established, we start measuring results against targets and adjusting. This is where the fractional model proves its value — you get strategic course corrections from an experienced operator, not just more activity from a junior team running without direction.

How We Work

A fractional CXO operates 2-3 days per week with your team. This includes attending leadership meetings, running marketing standups, managing vendors, and doing the strategic work that moves the needle. We're available throughout the week for urgent decisions — this is not a consulting engagement where we disappear between scheduled calls.

The first 30 days are immersive. We need access to everything — CRM, analytics, product roadmap, board decks, and introductions to key customers. The diagnostic is only as good as the data it's based on.

From month 2 onward, we settle into a steady operating rhythm. Weekly team direction, biweekly strategy reviews with the CEO, monthly board reporting, and ongoing campaign and initiative management. We adapt our focus based on what's most urgent and impactful each week.

Typical engagements run 6-12 months. Some companies need fractional leadership through their next funding round. Others use us to build the foundation and then hire a full-time CMO. We help define the role, recruit candidates, and manage the transition.

Focused growth strategy with clear audience prioritization
Institutional sales readiness for healthcare and senior living buyers
Board-ready growth metrics and narrative
Marketing team development and eventual full-time leadership hire

If your eldertech / agetech company needs fractional cxo leadership, we should talk.

Expand your marketing team output with our experts

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.

Frequently asked questions

How much does a fractional CXO cost for an eldertech company?

Monthly fees range from $15K-$30K for 2-3 days per week of senior leadership. This is roughly one-third the fully loaded cost of a full-time CMO. For eldertech companies between Series A and Series B, this is typically the right investment level — you get senior strategic leadership without the burn rate of a full-time executive before the revenue supports it.

How does a fractional CXO help with institutional sales in eldertech?

Institutional healthcare buyers (health systems, PACE programs, senior living chains, insurers) have procurement processes that most startup teams aren't prepared for. A fractional CXO who has navigated these cycles before can build the right sales materials, establish the credibility signals, and guide your sales team through the process. This includes clinical evidence packaging, compliance documentation, and reference programs.

How is a fractional CXO different from hiring a marketing agency?

An agency executes specific marketing tactics — running ads, producing content, building websites. A fractional CXO sets the strategy that determines which tactics matter, in what order, and with what resources. The CXO also manages your team, coordinates agencies, reports to your board, and makes the organizational decisions that shape your growth trajectory. They're the strategic layer that agencies need above them to be effective.

What makes Winston Francois different for eldertech fractional CXO work?

We bring experience at the intersection of healthtech, consumer, and B2B — which is exactly where eldertech sits. Most fractional CMOs come from either pure consumer or pure enterprise backgrounds. ElderTech requires both — consumer empathy for end users and institutional selling skills for healthcare buyers. Our team has operated in regulated health verticals and understands the multi-stakeholder dynamics specific to aging.

How long should we plan on needing a fractional CXO?

Most eldertech companies benefit from 6-12 months of fractional leadership. The first 3 months build the strategic foundation and growth infrastructure. Months 4-6 prove the model with real pipeline and revenue data. After that, many companies are ready to hire a full-time growth leader — and we help recruit, evaluate, and onboard that person.

What stage of eldertech company is the right fit?

Post-product, pre-scale — typically companies with $1M-$20M in revenue that have some customer traction but haven't built a repeatable growth engine. If you're still in R&D with no customers, a fractional CXO is premature. If you're above $30M with an established marketing team, you need a full-time CMO, not a fractional one. The sweet spot is when you've proven the product works and need to prove the business works.